112
Views
11
CrossRef citations to date
0
Altmetric
Review

Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer

, &
Pages 6743-6756 | Published online: 06 Dec 2018

References

  • Instituto Nacional do Câncer [National Institute of Cancer]Câncer; tipos de câncer: mama [Cancer; types of cancer: Breast] Accessed January 1, 2018. Available at: http://www2.inca.gov.br/wps/wcm/connect/tipos-decancer/site/home/mamaAccessed November 12, 2018 Portuguese
  • LeeSCJainPAJethwaSCTripathyDYamashitaMWRadiologist’s role in breast cancer staging: providing key information for cliniciansRadiographics201434233034224617682
  • CardosoFCostaASenkusE3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Ann Oncol20172812311128327998
  • MayorSNICE updates guidance on early and advanced breast cancerBMJ2009338b81519244307
  • PadhaniARLecouvetFETunariuNMetastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancerEur Urol2017711819227317091
  • MoreauPSanMiguel JSonneveldPESMO Guidelines Committee lMultiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201728suppl_4iv52iv6128453614
  • LecouvetFEWhole-Body MR Imaging: musculoskeletal applicationsRadiology2016279234536527089188
  • KohDMBlackledgeMPadhaniARWhole-body diffusion-weighted MRI: tips, tricks, and pitfallsAJR Am J Roentgenol2012199225226222826385
  • ThoenyHCRossBDPredicting and monitoring cancer treatment response with diffusion-weighted MRIJ Magn Reson Imaging201032121620575076
  • KohDMCollinsDJDiffusion-weighted MRI in the body: applications and challenges in oncologyAJR Am J Roentgenol200718861622163517515386
  • PadhaniARKohDMCollinsDJWhole-body diffusion-weighted MR imaging in cancer: current status and research directionsRadiology2011261370071822095994
  • LecouvetFETalbotJNMessiouCEORTC Imaging GroupMonitoring the response of bone metastases to treatment with magnetic resonance imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging groupEur J Cancer201450152519253125139492
  • WoolfDKPadhaniARMakrisAAssessing response to treatment of bone metastases from breast cancer: what should be the standard of care?Ann Oncol20152661048105725471332
  • YangHLLiuTWangXMXuYDengSMDiagnosis of bone metastases: a meta-analysis comparing ¹8FDG PET, CT, MRI and bone scintigraphyEur Radiol201121122604261721887484
  • HwangSPanicekDMMagnetic resonance imaging of bone marrow in oncology, Part 2Skeletal Radiol200736111017102717492444
  • O’SullivanGJCartyFLCroninCGImaging of bone metastasis: An updateWorld J Radiol20157820221126339464
  • ValliniVOrtoriSBoraschiPStaging of pelvic lymph nodes in patients with prostate cancer: usefulness of multiple b value SE-EPI diffusion-weighted imaging on a 3.0 T MR systemEur J Radiol Open20163162127069974
  • MichaelsAYKeraliyaARTirumaniSHShinagareABRamaiyaNHSystemic treatment in breast cancer: a primer for radiologistsInsights Imaging20167113114426567115
  • BragaLSemelkaRCPietrobonRMartinDde BarrosNGullerUDoes hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients?AJR Am J Roentgenol200418251207121315100120
  • HamstraDARehemtullaARossBDDiffusion magnetic resonance imaging: a biomarker for treatment response in oncologyJ Clin Oncol200725264104410917827460
  • FigueirasRGPadhaniARGohVJNovel oncologic drugs: what they do and how they affect imagesRadiographics20113172059209122084189
  • PadhaniARGogbashianABony metastases: assessing response to therapy with whole-body diffusion MRICancer Imaging201111SpecAS129S14522185786
  • PadhaniARMakrisAGallPCollinsDJTunariuNde BonoJSTherapy monitoring of skeletal metastases with whole-body diffusion MRIJ Magn Reson Imaging20143951049107824510426
  • BlackledgeMDCollinsDJTunariuNAssessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility studyPLoS One201494e9177924710083
  • KosminMMakrisAJoshiPVAh-SeeMLWoolfDPadhaniARThe addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancerEur J Cancer20177710911628390297
  • WooSBHellsteinJWKalmarJRNarrative [corrected] review: bisphosphonates and osteonecrosis of the jawsAnn Intern Med20061441075376116702591
  • WoodJBonjeanKRuetzSNovel antiangiogenic effects of the bisphosphonate compound zoledronic acidJ Pharmacol Exp Ther200230231055106112183663
  • ChiandussiSBiasottoMDoreFCavalliFCovaMADi LenardaRClinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jawsDentomaxillofac Radiol200635423624316798918
  • García-FerrerLBagánJVMartínez-SanjuanVMRI of mandibular osteonecrosis secondary to bisphosphonatesAJR Am J Roentgenol2008190494995518356441
  • ParkSYYooIRLeeSYChungSKSohnHSEffect of colony-stimulating factor on FDG uptake in bone marrow of patients with breast cancerJ Nucl Med201253suppl 11123
  • SchmidtGPBaur-MelnykAHaugAComprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CTEur J Radiol2008651475818082989
  • MessiouCCookGReidAHThe CT flare response of metastatic bone disease in prostate cancerActa Radiol201152555756121498309